01141nas a2200313   4500000000100000008004100001260001300042653004400055653002300099653001200122653002200134653001600156653001600172653003000188653001100218653002300229653001700252653001200269653001200281653003500293653001600328100002000344245004300364856004100407300001000448490000700458520034800465022001400813       1989                            d  c1989 Mar10aAnti-Inflammatory Agents, Non-Steroidal10aAntibody Formation10aAspirin10aBenzenesulfonates10aChloroquine10aClofazimine10aCytotoxicity, Immunologic10aHumans10aImmunity, Cellular10aInflammation10aleprosy10aSplints10aSurgical Procedures, Operative10aThalidomide1 aPfaltzgraff R E00aThe management of reaction in leprosy.  uhttp://ila.ilsl.br/pdfs/v57n1a12.pdf  a103-90 v573 a<p>Reaction and the subsequent development of neuritis is the basis for the majority of the disabilities and deformities that occur in leprosy. All possible means to prevent, to treat, and to reverse every reaction should be employed in all-out effort to ultimately effect as ideal a functional status for the patient as can be attained.</p>
  a0148-916X